Skip to main content

Health Risks of Phthalates

Completed

A National Research Council committee will evaluate human health risks and the potential for conducting a cumulative risk assessment for phthalate esters. The committee will review critical scientific data and address questions related to human relevance of experimental data, modes of action, exposure information, dose-response assessment, and the potential for cumulative effects. In its evaluation, the committee will consider the strengths and weaknesses of cumulative assessment approaches. The committee will provide recommendations to EPA on conducting a cumulative risk assessment on phthalate chemicals, including additional research needed.

Description

A National Research Council committee will evaluate human health risks and the potential for conducting a cumulative risk assessment for phthalate esters. The committee will review critical scientific data and address questions related to human relevance of experimental data, modes of action, exposure information, dose-response assessment, and the potential for cumulative effects. In its evaluation, the committee will consider the strengths and weaknesses of cumulative assessment approaches. The committee will provide recommendations to EPA on conducting a cumulative risk assessment on phthalate chemicals, including additional research needed. The committee shall consider the applicability of its recommendations for conducting cumulative risk assessment for other chemical classes.This project is sponsored by the U.S. Environmental Protection Agency.The approximate start date for the project is September 28, 2007.A report will be issued at the end of the project in approximately 15 months.

Contributors

Committee

Chair

Member

Member

Member

Member

Member

Member

Member

Member

Member

Member

Member

Member

Sponsors

EPA

Staff

Ellen Mantus

Lead

Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.